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9 Abstract Metabolic syndrome and its various features
10 (obesity, hypertension, dyslipidemia, diabetes, and nonal-
11 coholic fatty liver disease) are increasing worldwide and
12 constitute a severe risk for the sustainability of the present
13 universal Italian health care system. Lifestyle interventions
14 should be the ﬁrst therapeutic strategy to prevent/treat
15 metabolic diseases, far before pharmacologic treatment.
16 The role of diet and weight loss has been fully ascertained,
17 whereas the role of physical activity is frequently over-
18 looked both by physicians and by patients. Physical activity
19 has favorable effects on all components of the metabolic
20 syndrome and on the resulting cardiovascular risk, the
21 cornerstone in the development of cardiometabolic dis-
22 eases. The quantity and the frequency of physical activity
23 necessary to produce beneﬁcial effects has not been deﬁned
24 as yet, but brisk walking is considered particularly appro-
25 priate, as it can be practiced by a large number of indi-
26 viduals, without any additional cost, and has a low rate of
27 injury. The effects of exercise and leisure time physical
28 activity extend from prevention to treatment of the various
29 components of the metabolic syndrome, as well as to mood
30 and quality of life. Any effort should be done to favor
31adherence to protocols of physical activity in the
32community.
33
34Keywords Diet  Exercise  Lifestyle  Metabolic
35syndrome  Physical activity
36Introduction
37The epidemic of metabolic disorders, driven by obesity,
38constitutes a challenge for health systems worldwide.
39Several factors are contributing to the increasing preva-
40lence of the various features of the metabolic syndrome
41(hypertension, dyslipidemia, and type 2 diabetes). Diet and
42lifestyle have a major role, coupled with genetics. Positive
43economic developments and better healthcare, favoring
44population aging, are expected to increase costs to levels
45no longer sustainable both in Western and in developing
46countries. For the hundreds of millions worldwide who
47have the ‘‘metabolic syndrome’’, lifestyle modiﬁcation is
48the most appealing approach because of its non-toxicity
49and high efﬁcacy, compared with medications, and physi-
50cal activity (PA) is a fundamental component.
51It is outside the scope of the present review to discuss
52the reason(s) and the real existence of the syndrome, i.e.,
53whether a residual risk exists above that conferred by
54individual features or old and new cardiovascular risk
55factors [1]. Lifestyle modiﬁcations are mandatory for the
56individual components, and more so when they sum up, not
57only in the case of overt disease, but also when the indi-
58vidual components are in the range of ‘‘pre-disease’’ (i.e.,
59prediabetes, prehypertension, mild dyslipidemia not
60requiring drug treatment or low-grade visceral fat accu-
61mulation) [2]. This is the reason for the progressive
62reduction of the diagnostic cut-offs that occurred along the
63years (Table 1) (see [3, 4].
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64 We discuss the evidence supporting a major role for PA
65 both in the prevention and treatment of metabolic disor-
66 ders, over and above the effects on weight loss. For the
67 individual components of the metabolic syndrome, the data
68 on hard outcomes (mortality and cardiovascular events)
69 will be separated from the effects on surrogate markers
70 (body weight, blood pressure, lipid, and glucose control).
71 Obesity
72 Obesity, namely abdominal obesity, is a well-proven risk
73 factor for coronary heart disease (CHD), whereas PA
74 reduces the risk [5]. Although the signiﬁcance of over-
75 weight and class I obesity on overall mortality has very
76 recently been challenged [6], weight loss is mandatory to
77 reduce cardiovascular risk in obese subjects and any
78 intervention on lifestyle includes PA as necessary compo-
79 nent. Limiting the importance of PA to weight loss is,
80 however, reductive; PA is a cornerstone for the treatment
81 of non-communicable disease, independently of weight
82 loss. The amount of calories burned by exercise is probably
83 of minor importance compared with the calorie deﬁcit
84generated by dietary restriction and PA only becomes
85pivotal for long-term weight loss maintenance [7].
86This view is supported by a very recent randomized
87controlled trial (RCT), comparing the effects of diet,
88exercise, or the combination of diet and exercise [8].
89Exercise signiﬁcantly improved the functional status,
90without any effect on body weight; diet signiﬁcantly
91reduced body weight, whereas combination treatment more
92signiﬁcantly improved physical performance. Similarly, in
93postmenopausal women, diet was more effective than a
94physical activity program on weight loss at 1 year (-8.5
95vs. -2.4 %), but the combination of diet ? physical
96activity produced additive effects (-10.8 %) [9].
97Pre-hypertension/hypertension
98Hypertension is an independent risk factor for cardiovas-
99cular disease and a relationship exists between blood
100pressure (BP) levels and CHD [5] in spite of remarkable
101advances in therapy [10]. Drug-treated hypertensive
102patients are still at risk for future cardiac events [11] and
103behavior therapy, including healthy diet and increased PA,
Table 1 Diagnostic criteria of the metabolic syndrome, as proposed by different International Agencies (see [3, 4])
WHO (1999) EGIR (1999) ATPIII (2001–rev
2005)
AACE (2003) IDF (2005–rev 2009)
Data required IR (upper quartile of
general population)
OR glucose C110 mg/
dL;
OR 2-h glucose
C140 mg/dL
IR OR fasting insulin, in the
upper quartile of general
population
NO diabetes
None High risk
for IR
OR BMI
C25 kg/m2
Ethnic-based WC:
Caucasian C94 cm
(men) or C80 cm
(women);
Asian C90 cm (men) or
C80 cm (women)
No. of
additional
abnormalities
C2 of the following C2 of the following C3 of the following C2 of the
following
C2 of the following
Glucose C110 mg/dL C100 mg/dL
OR on medications
C110 mg/dL;
2-h
C140 mg/dL
C100 mg/dL
OR on medications
HDL
cholesterol
\35 mg/dL (men);
\40 mg/dL (women)
\40 mg/dL \40 mg/dL (men),
\50 mg/dL
(women)
OR on medications
\40 mg/dL
(men),
\50 mg/dL
(women)
\40 mg/dL (men),
\50 mg/dL (women)
OR on medications
Triglycerides C150 mg/dL C150 mg/dL C150 mg/dL
OR on medications
C150 mg/dL C150 mg/dL
OR on medications
Obesity Waist to hip ratio:[0.9
(men),[0.85
(women);
OR BMI C30 kg/m2
WC C94 cm (men),
C80 cm (women)
WC[102 cm
(men),[88 cm
(women)
See required parameters
Blood pressure C140/90 mmHg C140/90 mmHg C130/85 mmHg
OR on medications
C130/
85 mmHg
C130/85 mm Hg
OR on medications
Other Microalbuminuria
WHO world Health Organization, EGIR European Group on Insulin Resistance, ATPIII Adult Panel Treatment III, AACE American Association
of Clinical Endocrinologists, IDF International Diabetes Federation, WC waist circumference, IR insulin resistance, BMI body mass index
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104 remains the background approach because of its beneﬁcial
105 effects from the pre-hypertensive stage [12].
106 In a systematic review of lifestyle interventions in
107 hypertensive patients, Dickinson et al. [13] found robust
108 evidence for the beneﬁcial effects of a healthy diet, aerobic
109 exercise, alcohol and sodium restriction, and ﬁsh oil sup-
110 plements. This evidence supports the prescription of a low-
111 sodium diet, or of a diet with the characteristics of the
112 Dietary Approaches to Stop Hypertension (DASH) pro-
113 gram [14]. The DASH diet, based on the computation of
114 servings, was speciﬁcally developed to help people prevent
115 or treat hypertension, by reducing the levels of total fat,
116 saturated fat and cholesterol, and increasing potassium,
117 calcium, magnesium, ﬁber, and proteins. Such dietary
118 changes have been shown to reduce blood pressure, mainly
119 systolic BP by 2–14 mmHg in about one month [14], also
120 depending on the amount of weight loss that may produce
121 an additional 5–20 mmHg reduction in systolic BP. In
122 subjects with prehypertension or stage-1 hypertension of
123 the PREMIER study, 180 min/week of PA or more, alone
124 or in combination with the DASH diet, signiﬁcantly redu-
125 ces the estimated CHD risk in an 18-month follow-up [15].
126 When superimposed upon dietary changes, exercise per
127 se may reduce both systolic and diastolic pressure by
128 another 5–7 mmHg [16], and exert favorable effects on a
129 variety of cardiovascular risk factors, in a dose-dependent
130 fashion, after correction for confounders [17]. Low levels
131 of cardio-respiratory ﬁtness are associated with a high risk
132 of mortality, and improved ﬁtness is associated with a
133 reduced mortality risk. In a 20-year follow-up of North
134 American women, low physical ﬁtness is associated with a
135 20 % increased risk of cardiovascular death for every
136 metabolic equivalent (MET) decrease in exercise capacity
137 [18]. Exercise training produces a graded dose response in
138 ﬁtness in sedentary, overweight, or obese postmenopausal
139 women at moderately high risk of cardiovascular disease
140 [19]. Also moderate levels of ﬁtness induced by exercise
141 are associated with a lower risk for all cause and cardio-
142 vascular disease mortality, both in individuals with ele-
143 vated BP and in those without a diagnosis of hypertension.
144 In both normotensive and hypertensive healthy seden-
145 tary individuals, any type of exercise (i.e., walking, jog-
146 ging, running, and cycling) is beneﬁcial, including
147 resistance training. Walking remains the preferred form of
148 exercise as it may be recommended by healthcare profes-
149 sionals to the majority of patients, even the elderly, with
150 few exceptions. A systematic search of the literature
151 identiﬁed 27 randomized controlled trials on the effects of
152 walking on blood pressure and nine of them were positive
153 [20]. The beneﬁcial effect on blood pressure control is
154 mainly observed in trials of moderate- to high-intensity
155 walking and of longer duration, suggesting that recom-
156 mendations should focus on walking intensity and
157treatment adherence [20]. Regular walking programs and
158pedometers for monitoring PA may favor adherence to
159exercise programs in normotensive, overweight adults.
160Pedometers may also increase the motivation for PA; they
161were used to monitor walking programs in 26 studies (8
162randomized controlled trials and 18 observational studies),
163where pedometer users signiﬁcantly increase PA by 26.9 %
164over baseline. A goal of 10,000 steps/day is necessary to
165achieve the desired effects, i.e., reduced BP and reduced
166BMI [21]. In a recent study, walking decreased adjusted
167mean systolic and diastolic blood pressure by 7–9 % [22].
168The PA-induced effects on BP translate into reduced
169morbidity and mortality in hypertensive patients. When
170self-reported PA was graded in a prospective, randomized
171hypertension study (the LIFE study) exercising[30 min
172twice/weekly is associated with a reduced cardiovascular
173death, stroke, and myocardial infarction in hypertensive
174patients with left ventricular hypertrophy in a 4.8-year
175follow-up [23]. Aerobic exercise combined with dietary
176modiﬁcation (DASH diet) in sedentary overweight and
177obese patients with high BP (above the cut-offs for the
178metabolic syndrome) also improved neurocognitive func-
179tioning [24]. In a short-term trial, aerobic exercise con-
180sisting of moderate-to-vigorous intensity exercise
181according to current guidelines [25] also reduced both
182radial and femoral pulse wave velocity [26]. Similarly,
183exercise training and weight reduction (cycle ergometer
184training twice a day, 5 days a week, and hypocaloric diet)
185in patients with drug-treated hypertension reduced BP and
186cardiovascular risks, and improved abnormal left ventric-
187ular relaxation [27].
188It is deﬁnitely time to move from interventions limited
189to specialist centers to community-based PA implementa-
190tion for the control of hypertension, with the support of
191new technologies to stimulate adherence. In subjects aged
19260 and over with mild to moderate hypertension, a 6-month
193community-based walking intervention based on self-efﬁ-
194cacy theory, including both face-to-face and telephone
195support designed to assist participants to increase their
196walking, decreases systolic blood pressure by 15 mmHg,
197with no difference in diastolic pressure [28].
198Dyslipidemia
199Less than optimal lipid and lipoprotein levels, particularly
200elevated levels of low-density lipoprotein (LDL) choles-
201terol, increase the risk for morbidity and mortality from
202CHD throughout the range of lipid and lipoprotein values
203[29]. Lifestyle intervention should be the ﬁrst therapeutic
204strategy for ‘‘cardio-metabolic’’ patients and international
205agencies recognize regular PA as an essential component
206of a lifestyle modiﬁcation program [29].
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207 High levels of PA and cardio-respiratory ﬁtness are
208 associated with reduced risks of morbidity, mortality, and
209 improvement of their prognostic risk factors [30, 31], but
210 the optimal intensity or amount of exercise necessary for
211 risk reduction is unknown. As for hypertension, brisk
212 walking is the most commonly suggested type of PA.
213 Current guidelines suggest moderate intensity activity for
214 C30 min/session at least 5 days/week, but there is no
215 deﬁnite evidence on the amount of exercise conferring
216 speciﬁc health beneﬁts.
217 In sedentary overweight men and women, increasing the
218 amount and intensity of exercise signiﬁcantly reduces
219 small, dense LDL particles, increases LDL particle size and
220 high-density lipoprotein (HDL) cholesterol, and reduced
221 triglyceride levels. Improvements are neither related to the
222 intensity of exercise or improved ﬁtness, nor to the mini-
223 mal weight change, but only to the amount of activity [32].
224 A meta-analysis of 25 studies including over 1,000 subjects
225 conﬁrms that regular PA reduces the ratio of total to HDL-
226 cholesterol (decreasing by about 6 %), as well as the
227 plasma levels of HDL-cholesterol and triglycerides [33],
228 although the latter changes are not statistically signiﬁcant.
229 The independent effects of exercise intensity and amount
230 have not been conclusively established yet. A systematic
231 review of 28 randomized studies of moderate-to-hard intensity
232 PA for 12 weeks or longer shows a large variability in lipid
233 response, with a signiﬁcant increase in HDL-cholesterol levels
234 in approximately 40 % of trials [34]. In a more recent trial on
235 sedentary treatment-naı¨ve adults (almost two-thirds women),
236 comparing four exercise regimens (moderate vs. hard intensity
237 and low vs. high frequency in a 2 9 2 model), the hard-
238 intensity high-frequency exercise regimen is the only inter-
239 vention that produces a signiﬁcant improvement in HDL cho-
240 lesterol compared with physician advice alone, suggesting that
241 both intensity and frequency are important [35]. In a different
242 study [32], the high-intensity high-volume exercise, not the
243 high-intensity low-volume or the low-intensity low-volume
244 exercise over 8 months signiﬁcantly increases HDL-choles-
245 terol level. Thus, changes in HDLmay depend on the intensity,
246 frequency, and volume of exercise, and on the individual’s
247 baseline level [34]. In amore recent trial [36], patients assigned
248 to high-amount exercise show improvements in HDL size,
249 which are sustained for up to 2 weeks after exercise with-
250 drawal. This beneﬁt may be clinically important, as HDL-
251 cholesterol particles have anti-inﬂammatory, antioxidative,
252 anti-platelet, anticoagulant, and pro-ﬁbrinolytic activities, in
253 addition to their role in reverse cholesterol transport.Moreover,
254 moderate-intensity, but not vigorous-intensity, exercise results
255 in a sustained reduction in very low-density lipoprotein
256 (VLDL)-triglycerides over 15 days of detraining.
257 Historically, LDL cholesterol has long been considered
258 a primary risk factor for cardiovascular disease, but the
259 multinational INTERHEART study shows that the
260apolipoprotein (apo)B/apoA-I ratio is the most important
261modiﬁable predictor of myocardial infarction [5]. ApoB is
262a direct measure of the number of atherogenic particles as
263there is a single apoB molecule present on the surface of all
264LDL, intermediate density lipoprotein, and VLDL parti-
265cles. ApoA-I is the major protein on HDL particles and
266thus provides an indication of the number of anti-athero-
267genic particles [37]. Cross-sectional studies associate lower
268apoB levels with high levels of PA [38] and longitudinal
269studies show that regular exercise reduces apoB by up to
27020 % [39]. In physically inactive, middle-aged men who
271are overweight, PA reduces apoB levels as well as the
272apoB/apoA-I ratio without effect on LDL cholesterol [39].
273Finally, in obese and insulin-resistant patients, moderate
274PA is associated with decreased apoB/apoA-I ratio and
275increased apoA-I, whereas vigorous PA is required to
276observe a reduction in apoB [40], after adjustment for
277smoking, systolic blood pressure, and waist circumference.
278In summary, PA has a remarkable effect on the lipid
279proﬁle, one of the most relevant modiﬁable risk factors for
280CHD morbidity and mortality. This conclusion has, how-
281ever, been challenged by a very recent paper showing that
282objectively measured sedentary time is the most important
283lifestyle factor associated with a poor metabolic proﬁle
284(altered triglycerides, HDL-cholesterol, glucose) after
285adjustment for BMI and moderate-to-vigorous physical
286activity [41]. These data further indicate the importance of
287implementing leisure-time PA in the community to reduce
288the burden of metabolic diseases, as sedentary behavior,
289per se, is associated with increased cardiovascular mor-
290tality [42].
291Prediabetes/diabetes
292There is strong evidence that the occurrence of both pre-
293diabetes and type 2 diabetes (T2DM) is strictly associated
294with low cardio-respiratory ﬁtness. In a seminal report of
295the Nurses’ Health Study, Hu et al. [43] report that the
296relative risk of developing T2DM is reduced across quin-
297tiles of time spent per week on each of eight common PAs,
298including walking, during an 8-year follow-up (over half
299million person-years). Faster than usual walking pace is
300independently associated with decreased risk, but equiva-
301lent energy expenditures similarly promoted risk reduction.
302Several clinical trials conﬁrm that PA is an effective tool
303for the prevention and management of altered glucose
304metabolism.
305Prevention studies (Table 2)
306Four large-scale, multi-centre, randomized clinical trials
307are the corner stones in the evidence of the beneﬁts of PA
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308 in a prediabetic population. The US Diabetes Prevention
309 Program (DPP) reports a 58 % reduction in the incidence
310 of T2DM after an average of 2.8 years of lifestyle inter-
311 vention aimed at 150 min/week of moderate-intensity PA
312 and dietary restriction to induce a 7 % weight loss [44]. A
313 perfectly identical risk reduction of 58 % is associated with
314 lifestyle changes in the Finnish Diabetes Prevention Study
315 (DPS) [45]. In Asian Indians with impaired glucose toler-
316 ance (IGT), lifestyle modiﬁcations, including 210 min/
317week of brisk walking and dietary modiﬁcations, reduces
318the risk of incident diabetes by 28 % [46], whereas the
319Chinese Da Qing study demonstrates a risk reduction of
320incident diabetes of 31, 46, and 42 %, respectively, in
321subjects with IGT in a follow-up of 6 years of three
322intervention groups (diet only, exercise only, and diet plus
323exercise), independent of obesity [47]. Long-term follow-
324ups of these studies conﬁrm that systematic interventions to
325improve lifestyle habits maintain the beneﬁcial effects up
Table 2 Most important RCT on physical activity (with/without dietary counseling) in the prevention of type 2 diabetes
Study (Ref.) No.
Pz.
Arms Objectives Study
duration
and
follow-up
Results
Finnish Diabetes
Prevention
Study [45, 50]
522 Intensive
lifestyle
Control
Weight loss C5 %
Total intake of fat\30 %
Saturated fat\10 %
Intake of ﬁber C15 % for 1,000 kcal
C30 min/day of moderate-intense PA
3.2 years
(F-UP, 3
years)
Progression to T2DM:
-58 % during the intervention
period,
-36 % during F-UP
US Diabetes
Prevention
Program [44,
48]
3,234 Intensive
lifestyle
intervention
(ILI)
Metformin
(MET)
Placebo (PL)
Weight loss C7 %
C150 min/week of moderate PA
3.2 years
(F-UP
10 years)
Progression to T2DM:
-58 % (ILI), -31 % (MET)
during the study
No differences in T2DM incidence
in F-UP (most cases received ILI
in MET and PL groups)
Overall 10-years effect: -34 %
(ILI), -18 % (MET)
Da Qing Chinese
study [47, 49]
577 Only diet
Only PA
Diet ? PA
Control
Weight loss of 0.5–1.0 kg/month,
Increase in PA[1–2 U/day (1 U = 30 min of
mild PA, 20 min if moderate, 10 min if
intense, 5 min if very intense)
25–30 kcal/kg (55–65 % CHO, 10–15 %
protein; 25–30 % fat)
Increase in vegetables
Reduced alcohol and CHO intake
6 years Progression to T2DM:
-31 % (diet), -46 % (PA), -
42 % (diet ? PA) during the
study period
Cumulative incidence of T2DM
during the 20-year F-UP: 80 %
combined treatment, 93 %
placebo group
Indian Diabetes
Prevention
Program [46]
531 Lifestyle
(LSM)
Metformin
(MET)
LSM ? MET
Control
Reduced total calorie intake
Reduced CHO and fat intake
No sugar
Increased ﬁber intake
Moderate PA[30 min/day
30 months Progression to T2DM:
-28,5 % (LSM), -26,4 % (MET),
-28,2 % (LSM ? MET)
DPP in Primary
Care [52]
241 Coach-led
group
Self-directed
intervention
Usual care
Lifestyle change coaching and support
remotely-through secure email within an
electronic health record system and the
American Heart Association Heart360
15 months Weight loss[7 %:
37.0 % (coach-led group), 35.9 %
(self-directed group), 14.4 %
(usual care)
Korean National
Health
Insurance
Corporation
[52]
7,233 Exercise
group
Control
Warm-up, (10–15 min), aerobic (25–30 min;
e.g., treadmill or cycling), resistance
(10–15 min; e.g., bench press, arm curl, etc.)
and cool-down (10–15 min; relaxation and
stretching)
3 times/week for 6 months
2 years Progression to T2DM: -23 %
Weight: -1.5 kg
Waist circumference: -3 cm
CHO carbohydrates, DPP Diabetes Prevention Program, F-UP follow-up, ILI intensive lifestyle intervention, LSM lifestyle modiﬁcations, MET
metformin, PL placebo, RCT randomized controlled studies, PA physical activity, T2DM type 2 diabetes mellitus
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326 to 20 years [48–51]. Of note, the methodology of the
327 Diabetes Prevention Program also is effective in a primary
328 care setting, coupled with technology to increase physi-
329 cian–patient communication (E-LITE study) [52].
330 All these studies were carried out adding nutritional
331 modiﬁcation/counseling to PA. A recent prospective cohort
332 study observed the effects of a 6-month program based on
333 exercise only (300 min/week of moderate-intensity exer-
334 cise) in a large group of Korean subjects with normal or
335 impaired fasting glucose [53]. During a 2-year follow-up,
336 regular exercise is associated with a 23 % risk reduction of
337 incident T2DM, particularly in subjects with overweight/
338 obesity, where reduced waist circumference and BMI are
339 associated with reduced fasting glucose levels. These
340 results are in keeping with the hypothesis that regular
341 exercise might prevent diabetes via reduced obesity or
342 body fat redistribution, a conclusion not fully supported by
343 obesity studies [8]. The EPIC-InterAct case-cohort study
344 speciﬁcally addressed the relative role of PA and weight
345 loss on incident T2DM in men and women [54]. Higher
346levels of PA are associated with a signiﬁcant risk reduction
347across BMI categories, in the presence and absence of
348visceral adiposity, conﬁrming that PA prevents T2DM
349regardless of adiposity and weight loss.
350Based on the above evidence, health agencies recom-
351mend at least 150 min/week of moderate to vigorous aer-
352obic-based exercise to prevent T2DM, but we need to move
353from a prescriptive model to a comprehensive battle
354against sedentary lifestyle [41, 55].
355Intervention studies (Table 3)
356The beneﬁcial effects of PA and improved cardiorespira-
357tory ﬁtness on metabolic control in T2DM ﬁnds support in
358the Look AHEAD (Action for Health in Diabetes) study.
359This multicenter randomized controlled trial of over 5,000
360overweight or obese people with T2DM transposed the
361general framework of the Diabetes Prevention Program in
362the ﬁeld of intervention. An intensive lifestyle intervention
363(ILI), aimed at achieving and maintaining a weight loss of
Table 3 Randomized controlled studies of physical activity intervention in individuals with T2DM
Study (Ref.) No.
Paz.
Arms Objectives Follow-
up
Results
Di Loreto et al. [59,
60]
182 Behavioral approach
Control
Energy expenditure[10 MET/h/
week from baseline PA levels
Diet (55 % CHO, 30 % fat, 15 %
protein)
-300 kcal/die if BMI[25 kg/m2
2 years Targets achieved:
69 % intervention; 18 % control;
Signiﬁcant improvements in BMI,
blood pressure, HbA1c, T2DM costs
Look AHEAD Study
[56–58]
5,145 Intensive lifestyle
intervention (ILI)
Diabetes support
and education
(DSE)
Weight loss C7 % at 1 year and
long-term maintenance
1,200–1,800 kcal depending on the
initial weight
Total fat\30 %
Saturated fat\10 %
Protein C15 %
175 min/week of moderate PA
4 years Results at 4 years:
weight loss: -6.15 % (ILI) vs. -0.88
(DSE)
Fitness: ?12.7 vs. ?1.9 %
HbA1c: -0.36 % (ILI) vs. -0.09 %
(DSE)
Improvement in BP and dyslipidemia
Remission of T2DM:
9.2, 6.4, and 3.5 % at 2, 3, 4 years in
ILI vs. 1.7, 1.3, 0.5 in DSE
Italian Diabetes
Exercise Study
[61–63]
606 Exercise (EXE)
Control
150 min/week of PA (aerobic and
resistance training) in 2 sessions
Diet (55 % CHO, 30 % fat, 15 %
protein)
-500 kcal/die if BMI[25 kg/m2
1 year Results at 1 year:
HbA1c: -0.49 % (EXE) vs. -0.10 %
(control)
Improvement in blood pressure and
dyslipidemia (EXE)
Increase in VO2max (EXE),
independently of WL
Bacchi et al. [64] 40 Aerobic group
(AER)
Resistance group
(RES)
3 times/week for 60 min 4 months Short-term results:
HbA1c: -0.40 % (AER) vs. -0.35 %
(RES)
VO2peak: 4 ml
-1 kg min-1 (AER) vs.
2.1 (RES)
AER aerobic activity group, BMI body mass index, BP blood pressure, CHO carbohydrates, DSE diabetes support and education, EXE exercise,
ILI intensive lifestyle intervention, MET metabolic equivalent, PA physical activity, RES resistance activity group, T2DM type 2 diabetes
mellitus, VO2 oxygen consumption, WL weight loss
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364 7 % through diet and increased PA (175 min/week) was
365 compared with standard education. The primary endpoint
366 of the study was a composite outcome consisting of inci-
367 dent cardiovascular events, to be tested after a programmed
368 follow-up of 13.5 years. The results at 12- and 48-month
369 follow-up in over four thousand individuals are encourag-
370 ing: subjects who completed the 1-year trial improve their
371 cardiorespiratory ﬁtness (assessed using a sub-maximal
372 graded exercise test) [56], after adjustment for baseline
373 ﬁtness (20.9 % in ILI vs. 5.7 %; P\ 0.001) and also a
374 modest weight loss (5–10 %) is associated with improved
375 cardiovascular risk factors. These beneﬁts are partly
376 maintained at 4 years [57]. However, a very recent re-
377 analysis of ongoing data showed that the expected differ-
378 ences in cardiovascular outcome could no longer be
379 attained and the study was terminated because of futility on
380 October 2012. Termination was unexpected, also consid-
381 ering that the study had shown remission of diabetes in up
382 to 10 % of treated cases in the ILI group, compared with
383 1–2 % in the standard care group [58].
384 In the Italian setting, Di Loreto et al. [59] show that
385 2 years of regular aerobic exercise in a diabetic population
386 reduces all aspects of the metabolic syndrome. Any graded
387 10 MET-h/week of PA (corresponding to a 30-min walk/
388 day), after a course of structured PA, reduces BMI and
389 improves HbA1c [60]. Of note, in the intervention group,
390 drug treatment, and the overall direct cost of diabetes are
391 reduced in parallel with decreased estimated 10-year cor-
392 onary risk [59].
393 Also the type and mode of PA can make a difference. In
394 the Italian Diabetes and Exercise Study (IDES) an ILI
395 based on planned and supervised, mixed exercise (aerobic
396 and resistance training) improved HbA1c and reduced the
397 cardiovascular risk [61]. The intensive program of
398 150 min/week in two divided sessions of aerobic and
399 resistance exercise supervised by a trainer, associated with
400 dedicated counseling produced signiﬁcant beneﬁts in a
401 12-month follow-up; patients started exercising also out-
402 side gym sessions [61] and their quality of life improved
403 systematically in relation to the attained PA volume. In a
404 pre-speciﬁed analysis of the IDES cohort, the beneﬁts of
405 PA/exercise are once again independent of weight loss
406 [62], and in low-ﬁtness, sedentary individuals with T2DM,
407 increasing exercise intensity was not harmful, but did not
408 provide additional beneﬁts on cardiovascular risk factors
409 [63]. The beneﬁts of resistance exercise were conﬁrmed in
410 the RAED2 study [64] and in insulin-treated T2DM [65].
411 Nonalcoholic fatty liver disease (NAFLD)
412 Non-alcoholic fatty liver disease is characterized by liver
413 triglyceride accumulation (steatosis) in subjects with no
414history of excessive alcohol intake. NAFLD encompasses a
415large histological spectrum, from simple steatosis, to non-
416alcoholic steatohepatitis (NASH), ﬁbrosis and cirrhosis,
417potentially progressing to hepatocellular carcinoma [66]. It
418is the most common cause of chronically elevated liver
419enzymes and chronic liver disease, affecting 20–35 % of
420the general adult population in the Western countries.
421Although the prevalence is higher in the age group between
42240 and 70 years, NAFLD is present in almost all age ran-
423ges, including the pediatric population, with a prevalence
424of *10 % in children and adolescents, which is expected
425to rise sharply as an effect of the growing epidemic of
426obesity in childhood and adolescence [67].
427NAFLD is regarded as the hepatic expression of the
428metabolic syndrome, considering its close association with
429all its components [66, 68], similar pathophysiological
430mechanisms based on insulin resistance [69], and a similar
431cardiovascular risk [70]. Liver fat is indeed associated with
432a diffuse cardiovascular involvement (increased intima-
433media thickness and the presence of carotid plaques),
434independently of the presence of T2DM, and by endothelial
435dysfunction [71]; the outcome is strictly dependent on
436cardiovascular events [72], adding to liver-associated
437morbidity and mortality, as well as to cancer mortality [73].
438In the absence of speciﬁc pharmacological treatments
439and considering the strong association between NAFLD,
440metabolic syndrome, insulin resistance and other metabolic
441abnormalities [74], prevention and treatment are mainly
442directed at improving insulin sensitivity and at correcting
443cardiometabolic risk factors [66, 75]. These objectives are
444achieved through a ﬁrst-level intervention that consists in
445lifestyle change, calorie restriction, and increased PA. PA
446is expected to achieve these objectives, independently of
447weight loss [76, 77]. The beneﬁcial effects of exercise on
448liver steatosis and biochemical tests became clinically
449signiﬁcant after a very short-term program of aerobic
450exercise (treadmill walking for 60 min/day on 7 consecu-
451tive days at 85 % of maximal heart rate): the biochemical
452proﬁle is improved, the markers of hepatocyte apoptosis
453are reduced, and the whole body fat oxidation is increased
454[78]. Exercise programs of longer duration (4 weeks to
4556 months) generate additional beneﬁts and reduce the
456intrahepatic triglyceride content [77, 79], serum amino-
457transferase levels [80], insulin resistance [81, 82], and even
458improve the histological pattern (NAS score at liver
459biopsy) [83] in relation to changes in body weight or body
460composition [83]. These beneﬁts are also demonstrated in
461adolescents [84]. However, no study has so far demon-
462strated a signiﬁcant effect of behavior treatment (including
463PA implementation) on hard outcomes, including mortal-
464ity, cardiovascular events, or progression to cirrhosis.
465Individual reports of exercise interventions often have
466low sample sizes and insufﬁcient power to detect clinically
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467 meaningful hepatic beneﬁts and most of them include
468 contemporary dietary counseling, which does not allow an
469 independent evaluation of PA. In general, there are no
470 accepted criteria for the optimal intensity, duration, or total
471 volume of exercise to obtain these beneﬁcial effects and the
472 meta-analysis can only be used to substantiate the ‘global
473 beneﬁt’ of exercise therapy on liver fat. In a systematic
474 review with meta-analysis on the efﬁcacy of exercise
475 interventions (from 2- to 24-week duration, exercise on
476 2–6 days/week, intensity 45–85 % of VO2 peak), Keating
477 et al. [85] found six studies directly comparing exercise vs.
478 a non-exercise control arm on liver fat and serum ALT in
479 adults. In 6/12 selected studies, the results favor exercise.
480 By pooling the data (156 adults, mostly overweight or
481 obese), there is clear evidence for a systematic beneﬁt of
482 exercise on liver fat, with minimal or no weight loss. There
483 is no effect on serum ALT levels, which are normal at
484 baseline in several reports. In addition, PA improves car-
485 diovascular risk factors including hypertension, T2DM,
486 dyslipidemia, visceral adiposity and reduces the absolute
487 cardiovascular risk [85]. In a cross-sectional analysis of
488 subjects enrolled in the US NASH Clinical Research Net-
489 work, only vigorous exercise, not moderate exercise, nor
490 total duration or volume of PA, are associated with
491 decreased odds of having NASH or advanced ﬁbrosis [86].
492 The biological basis for this difference is unknown.
493 In conclusion, the intensity of PA/exercise may be an
494 important dimension to consider when counseling patients
495 and planning interventions. Intervention studies with
496 objective measures of PA are required to conﬁrm the dif-
497 ferential effects of vigorous compared with moderate PA
498 on NAFLD severity [87]. At present, experts recommend
49930 min of moderate intensity PA on most days of the week
500[81], or vigorous-intensity PA C3 times per week for C20
501min each time [87]. Implementation of PA remains the
502more demanding challenge because there is evidence that
503counseling about the beneﬁts of exercise or exercise pre-
504scription does not translate into positive outcomes [81].
505A lot of psychological and physical barriers reduce
506adherence to PA in NAFLD, and motivation may be low in
507most cases [88]. NAFLD subjects are characterized by a
508sedentary lifestyle [89, 90], also due to physical factors
509objectively limiting exercise, such as fatigue [91], reduced
510cardiorespiratory ﬁtness [90, 92], osteoarthritis linked with
511obesity and associated cardiovascular disease. From phy-
512sicians’ perspectives, the barriers to promote exercise as
513therapy for NAFLD are the scarce conﬁdence with edu-
514cational programs, lack of training in communication and
515group management, the awareness of future scarce adher-
516ence of patients, and their high dropout rate from lifestyle
517interventions [93]; from patients’ perspectives, barriers
518include climate factors, perceived effort of exercise and
519lack of time, as well as lack of self-efﬁcacy [94]. A
520structured program of cognitive behavioral therapy may
521favor lifestyle changes, increasing the probability to reduce
522body weight, to normalize liver enzymes, and to reduce the
523number of features of the metabolic syndrome [95].
524In conclusion, as with other chronic diseases related to
525unhealthy behaviors, we need a global strategy to reduce the
526burden of NAFLD [96]. Interventions should include strategies
527to promote regular contacts with a health care professional,
528self-monitoring, and individual goal setting, considering the
529large differences present in the community. This is the way to
530disseminate PA in a sedentary population [81].
Fig. 1 Beneﬁts of moderate-
intensity daily physical activity
(e.g., walking) on metabolic
disorders. Data combined from
a variety of references quoted in
the manuscript. DM diabetes
mellitus, HBP high blood
pressure
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531 Conclusions
532 The beneﬁcial effects of PA in the prevention and treat-
533 ment of non-communicable diseases clustered around the
534 metabolic syndrome are impressive (Fig. 1), but increasing
535 PA in the population remains difﬁcult [97]. Motivation to
536 exercise and to dietary changes are considerably different
537 and, in most cases, much lower for PA [88]. Data in NA-
538 FLD and unpublished data in a large cohort of subjects
539 with T2DM indicate that a large number of cases are either
540 in the pre-contemplation or contemplation stage of change
541 [98], i.e., they do not consider the possibility to engage in
542 PA to improve their disease. The possibility to attain the
543 desired targets of PA in patients requires skills and com-
544 mitment by physicians, as well as time and willingness by
545 patients [99], but a very low internal fracture (i.e., the
546 discrepancy between the present personal behavior and the
547 desired behavior) acts as a strong barrier against exercise
548 [88]. We need to move from the traditional prescriptive
549 approach to diet and exercising, towards a multidisciplin-
550 ary intervention, considering that barriers to physical
551 activity may be difﬁcult to overcome in individual cases,
552 and group support may make the difference. Primary care
553 might be the preferred setting to identify patients at risk,
554 but the implementation of PA counseling by GPs remains
555 difﬁcult because of time constraints in busy consulting
556 rooms [100]. We need to develop strategies to facilitate and
557 to disseminate education; the possibility to expand
558 patients’ adherence to activity programs by means of
559 information technology is a new area of interest that should
560 be extensively tested in the future. Web-based strategies
561 may indeed represent an opportunity to break down some
562 of the barriers (costs, lack of time, factors objectively
563 limiting spatial and temporal co-presence). A complete
564 integration of these systems, aimed at self-learning (on-line
565 learning without time or space restrictions), collaborative/
566 cooperative learning (forums, virtual communities), and
567 synchronous learning (virtual classrooms, video confer-
568 encing, chats) may represent the new frontier to motivate
569 and educate the very large number of people at risk, who
570 cannot attend specialist units.
571 Conflict of interest None.
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